Diabetic Mastopathy: A Case Report and Literature Review by Neetu, G. et al.
 
Case Rep Oncol 2010;3:245–251 
DOI: 10.1159/000318641 
Published online: July 16, 2010  © 2010 S. Karger AG, Basel 
ISSN 1662–6575 
www.karger.com/cro 
 
 
G. Neetu    Department of Pathology, Monash University Sunway Campus, Bandar Sunway 
Subang Jaya, Selangor 46150 (Malaysia) 
Tel. +60 355 146 319, Fax +60 355 146 323 
E-Mail neetu.gopinath @ med.monash.edu.my 
 
245
   
Diabetic Mastopathy: A Case 
Report and Literature Review 
G. Neetua    R. Pathmanathana    Ngun Kok Wengb  
aDepartment of Pathology, Monash University Sunway Campus, Bandar Sunway, 
Selangor, bDepartment of Surgery, Kuantan Specialist Hospital, Kuantan, Pahang, 
Malaysia 
 
Key Words 
Diabetic mastopathy · Insulin-dependent · Breast cancer · Pseudomalignancy 
Abstract 
Diabetic mastopathy is a rare fibroinflammatory breast disease characterized by 
lymphocytic lobulitis, ductitis, and perivasculitis with stromal fibrosis. This lesion often 
presents as a discretely palpable uni- or bilateral mass in long-standing type I diabetes 
and other autoimmune diseases. We report a case of insulin-dependent diabetic 
mastopathy, which presented clinically as an indeterminate breast lump suspicious for 
malignancy. The patient is a 36-year-old woman who had type 1 insulin-dependent 
diabetes mellitus. Mammography and ultrasonography raised a suspicion of malignancy, 
and an excisional biopsy was performed. A previous biopsy had shown no evidence of 
malignancy. Histopathological examination now showed dense keloid-like stromal 
fibrosis with epithelioid-like and spindly myofibroblasts and a characteristic lymphocytic 
infiltration around blood vessels in and around lobules and ducts, features consistent 
with diabetic mastopathy. The literature is briefly reviewed. 
Introduction 
Diabetic mastopathy (DMP) is a collection of clinical, radiological and histological 
features found in dense fibrous masses of the breast initially described by Soler and 
Khardori [1]. The disease is associated with long-standing type 1 insulin-dependent 
diabetes mellitus (IDDM) but has been reported in other autoimmune disorders. These 
patients present with a palpable hard, painless, irregular mass solitarily in one breast or 
bilateral breasts. The clinical and imaging findings are inconclusive, and these lesions are 
often misdiagnosed as breast carcinomas. The recognition of this rare but benign disease 
is crucial to avoid surgical biopsies which are more than necessary.  
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Case Presentation 
The patient described is a 36-year-old Chinese female, who presented with a lump in her left breast 
of 2 months’ duration. There was no associated pain, but she noticed an increasing discomfort in the 
lump during menstruation. She had been treated for type I diabetes for the last 7 years and had a 
secondary complication of diabetic retinopathy for which a photocoagulation therapy and vitrectomy 
was performed. She also had a history of autoimmune diseases, namely rheumatoid arthritis for the past 
12 years and thyrotoxicosis for the past 4 years, and was on steroid and antithyroid medication for both 
diseases, respectively. Investigations for autoimmune antibodies were not done on this patient. There 
was a family history of diabetes and arthritis. 
The examination showed a hard, relatively immobile, painless mass whose borders appeared to 
merge into the normal surrounding breast tissue. The mass was situated in the areolar region of the 
upper outer quadrant of the left breast, measuring approximately 5 cm. Axillary lymph nodes were 
absent and there was no history of nipple discharge. The right breast examination was unremarkable. 
Mammography revealed increased fibrofatty densities in both breasts with a subareolar nodular 
dense mass in the left breast. There were no microcalcifications detected. A poorly defined hypoechoeic 
mass at 11–12 o’clock position in the subareolar region of left breast was demonstrated on 
ultrasonogram. Breast imaging reporting and data system (BIRADS) categorization was an 
indeterminate breast lump, and hence the clinical impression was suspicion of breast carcinoma. A core 
needle biopsy followed by an excision biopsy was performed. The needle biopsy revealed stromal 
fibrosis on histopathology without the other constellating features. Gross pathology of the excision 
specimen demonstrated a whitish irregular firm fibrotic mass measuring 7 × 6 × 4 cm (fig. 1). There was 
no visible mass lesion in the specimen. Histologically, the lesion showed a striking lymphocytic lobulitis 
and ductitis (fig. 2) comprising small mature lymphocytes, a keloid-like stromal expansion (fig. 3) with 
increased stromal spindle cells, occasional epithelioid-like myofibroblasts and a prominent lymphocytic 
vasculitis (fig. 4). Plasma cells were rare and there were no germinal centers observed. The case met all 
the histologic parameters fitting the diagnosis of DMP. 
The patient currently remains well and is on follow-up. 
Discussion 
DMP is a rare entity of self-limiting fibroinflammatory disease of the breast associated 
with type 1 diabetes mellitus occurring in premenopausal women. 
Soler and Khardori [1] first described this disease in 1984 in patients with type 1 
IDDM. Most of the patients were women under 30 years of age with complications arising 
from diabetes such as retinopathy, neuropathy and nephropathy. The combination of 
stromal fibrosis and lymphocytic vasculitis in these patients was subsequently described 
as mastopathy in insulin-dependent diabetics by Byrd et al. [2]. 
Tomaszewski et al. [3] found that certain microscopic features like epithelioid cells in 
the fibrous stroma were specific for IDDM. The histopathologic criteria were further 
defined by Seidman et al. [4] who proposed a combination of histologic features to 
confirm diabetic mastopathy. These were a collagenous stroma with keloid-like features 
with a slightly increased concentration of stromal spindle cells and mature lymphocytes 
clustered circumferentially around small blood vessels as well as in and around lobules 
and ducts. They reported a mean duration of greater than 13 years (range 4–27 years) for 
DMP to develop. The disease was not limited to women but was exceptionally seen in 
men. 
In 1989, Logan et al. [5] mentioned criteria for the radiographical diagnosis of DMP, 
i.e. a long-term history of IDDM, hard palpable masses, mammographic dense glandular 
tissue and strong ultrasound acoustic shadowing. Nevertheless, these radiologic findings 
can still be mistaken for a malignancy. They advocated the use of fine needle aspiration 
cytology (FNAC) in the diagnosis of DMP. They mentioned the firm resistance  
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experienced during the back-and-forth motion of the needle, which was stronger than in 
the other breast, as a clue to the diagnosis of DMP. Unfortunately, DMP contains little 
cellular material, making cytological diagnosis difficult. This necessitates either core 
needle biopsy or excision biopsy for the first diagnosis. 
DMP has also been described in type II diabetes mellitus, though with a lower 
incidence compared with type I diabetes mellitus. Some researchers reported similar 
features in autoimmune diseases, like thyroiditis and systemic lupus erythematosus, 
where they described the condition as lymphocytic mastopathy [6]. In the present case 
report, our patient had type 1 diabetes mellitus, arthritis and thyrotoxicosis. 
Even though many reports have been published on DMP in radiology, pathology and 
surgical literature, this clinical condition is poorly recognized since breast examination is 
not routinely performed in young diabetic patients. DMP may be confused with breast 
carcinoma [7] because of the difficulty to distinguish between these two entities both 
physically and by imaging. In cases with an appropriate clinical history and high index of 
suspicion, an ultrasound-guided core biopsy was found to be useful for the primary 
diagnosis of DMP [8]. 
The pathogenesis of DMP is not completely understood, but many theories have been 
proposed considering a multifactorial etiology. Sternberg et al. [9] in their studies found 
that the glycosylation and increased intermolecular cross linkages in diabetics render 
collagen resistant to degradation. This leads to the accumulation of connective tissue 
characteristic of some connective tissue disorders in diabetics, including mastopathy. 
Tomaszewski [3] hypothesized that advanced glycosylated end products formed in 
hyperglycemia act as neo-antigen and trigger an autoimmune response with B-cell 
proliferation and autoantibody production. The resultant cytokine release would lead to 
matrix expansion. 
Lymphocytic mastitis in DMP is associated with B cell lymphocytes and nondiabetic 
mastitis shows a higher proportion of T cells [3]. In a study of the association of B cell 
lymphocytosis with marginal lymphoma, no risk of progression to malignant lymphoma 
was found [10]. DMP being a benign condition, immunohistochemistry of the lymphoid 
cells was omitted in our patient. 
Hunfeld and Bassler [11], who compared the stromal and lymphocytic features of 
DMP and non-diabetic lymphocytic mastitis, found that the latter has higher proportions 
of T cells and less pronounced fibrosis. DMP can be differentiated by the greater stromal 
fibrosis, lobular atrophy and the presence of epithelioid myofibroblasts. Our case showed 
similar epithelioid myofibroblasts in the stroma. 
Some researchers who studied the prognosis of DMP found that these lesions are 
prone to single or multiple recurrence in the same breast or the contralateral breast [12]. 
Camuto [13] reported that 60% of DMP recur after surgical excision and tend to be in the 
same location, involving more breast tissue than the preceding lesion; therefore, surgical 
biopsy should not be considered. 
Ely et al. [14] studied 19 patients who were followed up for 14 years and found that the 
recurrence rate was a substantial 32%. The authors questioned the specificity of the 
diagnostic criteria for DMP as these lesions were also found in type 2 diabetes and non-
diabetic patients. 
Long-standing IDDM in young women hence warrants a routine clinical examination 
of the breast. The recurrence can be managed conservatively in documented cases. Core  
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needle biopsy under ultrasound guidance eliminates redundant surgical procedures that 
may exacerbate the condition. This necessitates follow-up in such patients. 
It is important for the pathologists not to misdiagnose DMP as it can recur. The lesion 
can also simulate breast carcinoma, hence such patients may be spared from many 
unwarranted surgical biopsies if the radiologists and pathologists are aware of this rare 
breast disease. There is no evidence to suggest that DMP predisposes to the development 
of breast carcinoma or stromal neoplastic diseases. 
FNAC can be used to monitor patients with recurrent lesions in a proven case of DMP, 
as it can show ductal epithelial cells in clusters, lymphocytes and epithelioid fibroblasts, 
which are readily identified in connective tissue fragments [15]. 
Conclusion 
Recognizing DMP requires an awareness of the existence of this entity and a careful 
correlation of the patient’s clinical history with the physical, radiological and pathological 
examinations. As the disease can be managed conservatively but may recur, an accurate 
diagnosis is essential to avoid unwanted multiple surgical biopsies. Monitoring of the 
patients by FNAC would be sufficient once the pathologic diagnosis is confirmed. 
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Fig. 1. Gross specimen sectioned to reveal dense whitish fibrous stroma in diabetic mastopathy. 
 
 
 
Fig. 2. Histopathology showing lymphocytic ductitis on HE stain. 
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Fig. 3. Histopathology showing keloid-like stromal fibrosis with scattered myofibroblasts. 
 
 
 
Fig. 4. Histopathology showing perivascular lymphocytic infiltration. 
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